Borneol (CAS: 507‑70‑0) is a bicyclic monoterpene alcohol with the molecular formula C₁₀H₁₈O and a molecular weight of 154.25 g/mol. It appears as a white to off‑white crystalline powder or colorless plates with a characteristic piney, camphoraceous aroma. The compound is a chiral molecule existing in two enantiomeric forms — (+)-borneol (natural) and (−)-borneol — as well as a racemic mixture (DL‑borneol) produced synthetically. Its structure consists of a bicyclic camphane skeleton bearing a hydroxyl group in the endo position. Key physical properties include a melting point of 198‑208 °C, a boiling point of 212 °C, and solubility in alcohol, ether, and chloroform, but it is insoluble in water.
Borneol has a long history of use in traditional Chinese and Japanese medicine, where it is valued as a “messenger drug” that enhances the delivery of other active ingredients. In modern applications, it serves as a pharmaceutical intermediate, a bioavailability enhancer, an analgesic and anti‑inflammatory agent, a fragrance ingredient in fine perfumery and personal care products, a flavoring agent (FEMA 2157), and a precursor for the synthesis of bornyl esters and other terpene derivatives. Its production involves extraction from natural sources such as the camphor tree (Cinnamomum camphora) and Blumea balsamifera, as well as synthetic production via camphor reduction. Market demand is closely linked to the global pharmaceutical and fragrance industries, the rising popularity of natural and traditional medicine products, and increasing consumer preference for natural fragrances. Based on its chemical characteristics and industrial chain position, this article systematically analyzes international market dynamics of Borneol, focusing on core application scenarios, competitive landscape, regional differences, regulatory trends, and future outlook, providing strategic references for industry participants.
Core Application Fields and Demand
Market demand for Borneol is concentrated in four major sectors: pharmaceuticals and traditional medicine (≈40‑45% of global consumption), fragrances and personal care (≈25‑30%), flavors and food applications (≈10‑15%), and chemical intermediates and industrial applications (≈10‑15%).
In the pharmaceutical and traditional medicine sector, Borneol is widely used as a bioavailability enhancer and “messenger drug” in traditional Chinese medicine (TCM) formulations, where it improves the delivery of active ingredients to the brain and other target tissues. It is documented in the Chinese Pharmacopoeia and utilized in pharmaceutical formulations across China, particularly for cardiovascular and cerebrovascular indications. DL‑Borneol has been shown to enhance the systemic exposure of Panax notoginseng saponins by 1.9‑3.7 fold at a 1:1 compatibility ratio. The compound also delivers TRPM8‑dependent, opioid‑independent analgesia (EC₅₀ = 65 μM), enabling opioid‑sparing formulation development. In modern pharmaceuticals, Borneol is used as an intermediate in the synthesis of various natural products, including essential oils and fragrances. It is also employed as a reference standard for analytical method development, method validation (AMV), and quality control (QC) in abbreviated new drug applications (ANDA). The global pharmaceutical industry has gradually grown in recent years as the population is ageing and health services have been strengthened, driving demand for Borneol.
In the fragrances and personal care sector, Borneol is a key ingredient in perfumes, essential oils, decorative cosmetics, fine fragrances, shampoos, toilet soaps, and other toiletries, as well as in non‑cosmetic products such as household cleaners and detergents. Its pleasant piney, camphoraceous aroma makes it a preferred choice for creating unique and appealing fragrances. The compound serves as a fragrance fixative and is also used in the manufacture of its esters, which are valuable in perfumery and incense. The rise in disposable incomes in emerging markets and improved living standards of the middle class are anticipated to propel the perfume industry forward, further boosting demand for Borneol.
In the flavors and food applications sector, Borneol is listed as a flavoring agent with FEMA number 2157 and JECFA number 1385. It is used in the food industry to impart a camphoraceous, fragrant, and green flavor profile. The compound is safe when used as a flavoring agent in food.
In the chemical intermediates and industrial applications sector, Borneol serves as a key intermediate in the synthesis of various natural products, including essential oils and fragrances. It is also used in the production of its esters (e.g., bornyl acetate, bornyl isobutyrate) and as a starting material for the synthesis of other terpene derivatives.
Major Market Participants
The global supply system for Borneol follows a pattern of specialized chemical manufacturers, natural extract producers, and pharmaceutical ingredient suppliers, with production concentrated in Asia (particularly China), Europe, and North America. The Borneol market is characterized by a mix of established players, including large multinational chemical companies, specialty oil manufacturers, and smaller niche brands specializing in natural health and wellness products.
Key international suppliers and manufacturers include Santa Cruz Biotechnology, Inc., Tokyo Chemical Industry (TCI) (offering Borneol with purity >70.0% GC, containing ca. 20% Isoborneol, in pack sizes from 25g to 500g), Sigma‑Aldrich (Merck) (offering L‑Borneol, product B7888), SynZeal (supplying Borneol with detailed characterization data compliant with regulatory guidelines for ANDA filing and method validation), Chem‑Impex (offering Borneol Camphol), Parchem (offering Borneol Flakes with FEMA 2157 certification), and BenchChem (offering DL‑Borneol in standard pack sizes from 5 mg to bulk custom).
In Asia, key producers include Hunan Sonbon Forestry Science & Technology Co., Ltd. (China), VDH Organics Pvt. Ltd. (India), and various Chinese manufacturers such as Jiangxi Xuesong Natural Medicinal Oil Co., Ltd. (江西雪松天然药用油有限公司) and Foreverest Resources Ltd.. The compound is generally supplied as a white to off‑white crystalline powder or flakes with purity ranging from 70% (technical grade, containing isoborneol) to ≥97‑99% for high‑purity pharmaceutical and analytical grades.
Shanghai XinChem Co., Ltd. (XinChem) has established a reliable, quality‑controlled supply chain for high‑purity Borneol (CAS 507‑70‑0). Our product is manufactured under strict quality management, achieving consistent purity (≥97‑99%) with low impurity profiles, fully complying with global pharmaceutical, fragrance, and food standards. It is available in pharmaceutical grade (suitable for TCM formulations, bioavailability enhancement, and API synthesis), fragrance grade (for perfumery and personal care), and flavor grade (FEMA 2157 compliant).
Regional Market Dynamics
Global demand for Borneol shows regional differentiation: “Asia‑Pacific dominates production and consumption, North America and Europe are mature high‑value markets, and Latin America and Middle East & Africa are emerging growth regions.” The global Borneol market size reached a volume of 222.97 thousand metric tons (TMT) in 2024 and is projected to grow at a CAGR of 8.00% between 2025 and 2034 to reach nearly 481.38 TMT by 2034. The market is valued at approximately USD 50‑68.5 million (2023‑2024 estimates) with projections reaching USD 68.5‑4.72 billion by 2031‑2034, depending on the scope and methodology. The Asia‑Pacific region is expected to account for a significant portion of the global Borneol market due to the presence of numerous pharmaceutical companies and the product‘s significance in Chinese medicine.
Asia‑Pacific is the world‘s largest producer and consumer of Borneol, led by China, India, Japan, and Southeast Asian countries. China is projected to hold a leading share in the Borneol industry in the Asia‑Pacific region due to the product‘s extensive use in traditional Chinese medicine. The region benefits from abundant natural sources of borneol (camphor trees, Blumea balsamifera) and well‑established extraction and synthesis capabilities.
North America (United States and Canada) and Europe (Germany, France, United Kingdom, Netherlands) together account for a significant share of high‑purity pharmaceutical and analytical grade consumption. The Borneol industry in North America is expected to expand rapidly during the forecast period due to the rising production of biologic medicines in the region. Customer requirements in these regions are stringent: purity ≥97‑99%, full traceability, compliance with USP/EP pharmacopeial standards, and full impurity profiling.
Latin America and Middle East & Africa are emerging growth regions with increasing consumption of Borneol in pharmaceutical, fragrance, and personal care applications. Price sensitivity is higher in these regions, and Asian suppliers dominate trade flows.
Regulatory and Environmental Considerations
Borneol (CAS 507‑70‑0) is subject to regulatory oversight in major economies, particularly when intended for pharmaceutical, food, and cosmetic applications.
In the European Union, Borneol is registered under REACH (EINECS 208‑080‑0). The Council of Europe included Borneol in the list of substances granted B – information required – 28‑day oral study (COE No. 64). The compound is classified with GHS hazard statements: H302 (Harmful if swallowed) and H228 (Flammable solid). Precautionary measures include keeping away from heat, sparks, and open flames, and wearing protective gloves and eye protection. The compound is a flammable solid (UN 1312, Class 4.1, Packing Group III).
In the United States, Borneol was approved by the FDA for use as a flavoring agent and is listed with FEMA number 2157. The compound is regulated under TSCA. The FDA has approved Borneol for use in food and cosmetic applications.
In China, Borneol is listed in the Inventory of Existing Chemical Substances (IECSC) and is documented in the Chinese Pharmacopoeia. It is widely utilized in pharmaceutical formulations across China, particularly for cardiovascular and cerebrovascular indications.
Environmentally, Borneol has a calculated Log Kow of 2.85, indicating moderate lipophilicity. Its worldwide volume of use is estimated at 10‑100 metric tonnes per annum. The compound is slightly soluble in water (738 mg/L at 25 °C) and should be stored in a cool, dark place (recommended below 15 °C). Storage conditions: keep in a tightly sealed container in a dry, dark place; short‑term storage at 0‑4 °C, long‑term storage at ‑20 °C.
Future Outlook
The market outlook for Borneol is tied to four core drivers: (1) sustained growth in global pharmaceutical and traditional medicine consumption, driven by an ageing population, increased health awareness, and the rising popularity of natural and traditional medicine products; (2) expanding applications in the fragrance and personal care industry, fueled by increasing consumer preference for natural fragrances and exotic floral consumer products; (3) growing demand for Borneol as a bioavailability enhancer and analgesic in drug formulations; and (4) the rising production of biologic medicines in North America and the expansion of pharmaceutical manufacturing in Asia‑Pacific. The global Borneol market is projected to grow at a CAGR of 2.5‑10.17% through 2031‑2034, with the Asia‑Pacific region expected to remain the dominant production and consumption center.
Challenges include: competition from synthetic substitutes and alternative terpene alcohols (e.g., isoborneol, camphor), variable isoborneol content in commercial grades (up to ~40%) affecting product consistency, raw material availability and price volatility for natural sources, and increasing regulatory scrutiny on natural product claims. Enterprises should focus on securing high‑purity (≥97‑99%) production capabilities, maintaining rigorous impurity documentation for global regulatory filings, ensuring compliance with pharmacopeial standards (USP, EP, Chinese Pharmacopoeia), and building long‑term supply partnerships with pharmaceutical manufacturers, fragrance houses, and traditional medicine producers.
Shanghai XinChem Co., Ltd. (XinChem)
As a world‑leading supplier of pharmaceutical intermediates, natural terpene alcohols, and specialty chemicals, Shanghai XinChem Co., Ltd. (XinChem) has always focused on the innovative needs of the pharmaceutical, fragrance, flavor, and personal care industries. Relying on core advantages in sourcing, quality assurance, and global logistics, we provide high‑quality Borneol (CAS 507‑70‑0) to global customers. Our product is manufactured under strict quality management, achieving consistent specifications for pharmaceutical, fragrance, and food grades. Fully compliant with USP, EP, Chinese Pharmacopoeia, and international quality standards, it is an ideal pharmaceutical intermediate, bioavailability enhancer, fragrance fixative, and flavoring agent.
1. Technical Advantages
High Purity & Consistency: Our Borneol achieves purity levels of ≥97‑99% (verified by GC analysis), supplied as a white to off‑white crystalline powder, molecular weight 154.25 g/mol, melting point 198‑208 °C, boiling point 212 °C.
Low Impurity Profile: Strict control of isoborneol content, residual solvents, heavy metals, and related substances ensures high performance for pharmaceutical, fragrance, and food applications.
Multiple Grades Available: We offer pharmaceutical grade (suitable for TCM formulations, bioavailability enhancement, API synthesis, and analytical reference standards), fragrance grade (for perfumery and personal care), and food grade (FEMA 2157 compliant).
Batch‑to‑Batch Uniformity: Rigorous analytical testing (GC, HPLC, melting point, optical rotation for enantiomeric purity) guarantees consistent quality and reproducible performance across all production lots.
2. Product Advantages
Versatile Terpene Alcohol Platform: Directly used in pharmaceutical formulations (bioavailability enhancer, analgesic, anti‑inflammatory, cardiovascular and cerebrovascular indications), traditional Chinese medicine (messenger drug), fragrance compositions (fine perfumery, decorative cosmetics, shampoos, soaps, detergents), flavoring applications (FEMA 2157), and chemical synthesis (bornyl esters, terpene derivatives).
Proven Bioavailability Enhancement: DL‑Borneol enhances systemic exposure of active ingredients by 1.9‑3.7 fold in compatible formulations.
TRPM8‑Dependent Analgesia: Delivers opioid‑independent analgesia (EC₅₀ = 65 μM) for opioid‑sparing formulation development.
Excellent Fixative Properties: Provides long‑lasting piney, camphoraceous notes in fragrance compositions.
Flexible Packaging: 25g, 100g, 500g, 1kg, 5kg, and 25kg fiber drums; custom packaging for pharmaceutical and industrial orders.
Reliable Supply Chain: Annual capacity in the multi‑ton range, with dedicated warehousing (cool, dry, dark, <15°C recommended) and just‑in‑time delivery capabilities.
3. Application Fields
- Pharmaceuticals & Traditional Medicine: Bioavailability enhancer for TCM formulations, analgesic (TRPM8‑dependent), anti‑inflammatory agent, cardiovascular and cerebrovascular therapeutics, API intermediate, analytical reference standard for ANDA filing.
- Fragrances & Personal Care: Fine fragrances, decorative cosmetics, perfumes, shampoos, toilet soaps, toiletries, household cleaners, detergents, incense, and essential oils.
- Flavors & Food Applications: Flavoring agent (FEMA 2157) for foods, beverages, and confectionery.
- Chemical Synthesis: Precursor for bornyl acetate, bornyl isobutyrate, and other terpene derivatives.
4. Service Support
Our technical team provides enantiomeric purity analysis, impurity profiling, stability testing recommendations, and regulatory documentation (Certificate of Analysis, Technical Data Sheet, Safety Data Sheet, USP/EP compliance, Chinese Pharmacopoeia compliance, REACH compliance, TSCA certification). We offer custom packaging and just‑in‑time delivery.
5. Why Choose XinChem
- Professionalism: 20+ years in the pharmaceutical, fragrance, and specialty chemical industries.
- Flexibility: Tailored to customer purity specifications, grade requirements, packaging sizes, and regulatory documentation needs.
- Cost‑effectiveness: High quality at competitive industrial pricing.
Contact us now to start cooperation!
Website: www.xinchem.com
Email: sales1@xinchem.com
WhatsApp: +86 18049800532
Post time: Jul-19-2026